IGF2BP2 and thyroid gland carcinoma: Given the progressively increasing expression levels of IGF2BP2 across normal thyroid, PTC, PDTC, and ATC cell lines and tissues (Fig. 1D-G), we hypothesized that IGF2BP2 may contribute to the dedifferentiation phenotype in thyroid carcinoma.